Abstracts
Showing 807 abstracts.
Toxicity Tables Overestimate Neutropenia Among African HIV Exposed Uninfected Infants
Conference
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
Infectious Morbidity, Mortality and Growth of HIV-exposed, Uninfected, Formula-Fed Infants in Brazil and South Africa Enrolled in NICHD/ HPTN 040/ PACTG 1043
Conference
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
Study
P1043/HPTN 040
Lack of Identification of Adult TB Contacts in Infants with Microbiologically Confirmed or Clinically presumed TB (MCCP TB) in Clinical Trial P1041
Conference
6th IAS Conference on HIV Pathogenesis, Treatment and Prevention
Study
P1041
A comparison of DNA and plasma trofile results in a treatment experienced study population prior to initiation of new antiretroviral regimens
Conference
2011 Int'l Workshop on HIV & Hepatitis Virus Drug Resistance & Curative Strategies,
Study
A5241
Atazanavir dosing conversion and pharmacokinetics in HIV-infected children switching from atazanavir powder to capsules
Conference
12th International Workshop on Clinical Pharmacology of HIV Therapy
Study
P1020A
Authors
Jennifer J. Kiser, Richard M. Rutstein, Pearl Samson, Grace Aldrovandi, Lynne M. Mofenson, Elizabeth Smith, Jenny Zhang, Sophie Biguenet, Courtney V. Fletcher, The IMPAACT P1020A TeamPharmacokinetics of Increased Dose Atazanavir with and without Tenofovir During Pregnancy
Conference
12th International Workshop on Clinical Pharmacology of HIV Therapy
Study
P1026S
Methods for Choosing A Cut Point When Dichotomizing A Continuous Response – A Case Study of Predicting Infant Survival with High Resolution Melting Score
Conference
89th Int'l Association for Dental Research/40th American Association for Dental Research
Efficacy of Extended Daily Infant NVP through Age 6 Months Compared to 6 Weeks for Postnatal PMTCT of HIV through Breastfeeding
Conference
18th Conference on Retroviruses & Opportunistic Infections
Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1043/HPTN 040
Nevirapine (NVP)- vs. Lopinavir-Ritonavir (LPV/r)-Based Antiretroviral Therapy (ART) among HIV-Infected Infants in Resource-Limited Settings: The IMPAACT P1060 Trial
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1060